CORRESP Filing
BriaCell Therapeutics Corp.
Date: April 22, 2025 · CIK: 0001610820 · Accession: 0001641172-25-005681
AI Filing Summary & Sentiment
Reasoning
Letter
Re: BriaCell Therapeutics Corp.
April 22, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
F Street NE
Washington, D.C. 20549
Attention: Tyler Howes and Jason Drory
Registration Statement on Form S-1
CIK No. 0001610820
Filed April 22, 2025
Ladies and Gentlemen:
BriaCell Therapeutics Corp. (the "Company") hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it may become effective at 5:00 p.m. Eastern Time on April 24, 2025, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such time.
Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Sichenzia Ross Ference Carmel LLP, by contacting Christian Lichtenberger, Esq. at (646) 810-0591 or clichtenberger@srfc.law.
Very
truly yours,
/s/
William V. Williams
Show Raw Text
CORRESP 1 filename1.htm April 22, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549 Attention: Tyler Howes and Jason Drory Re: BriaCell Therapeutics Corp. Registration Statement on Form S-1 CIK No. 0001610820 Filed April 22, 2025 Ladies and Gentlemen: BriaCell Therapeutics Corp. (the "Company") hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it may become effective at 5:00 p.m. Eastern Time on April 24, 2025, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such time. Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Sichenzia Ross Ference Carmel LLP, by contacting Christian Lichtenberger, Esq. at (646) 810-0591 or clichtenberger@srfc.law. Very truly yours, /s/ William V. Williams William V. Williams Chief Executive Officer